The Filing Desk

IRADIMED vs Pulse Biosciences

IRADIMED IRMD · Pulse Biosciences PLSE · Health Care Equipment

IRADIMED reported revenue of $84 million in fiscal 2025, 279.3 times Pulse Biosciences' $0 million in fiscal 2025. IRADIMED had an operating margin of 31.2%, against -21982.6% at Pulse Biosciences. Free cash flow was $17 million at IRADIMED and −$54 million at Pulse Biosciences.

Side by side

IRADIMEDPulse Biosciences
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$84M$0M
Revenue growth14.4%—
Revenue growth a year, last 5 years21.5%—
Gross margin76.8%−54.0%
Operating margin31.2%−21,982.6%
Net margin26.8%−20,794.6%
Free cash flow$17M−$54M
Free cash flow margin20.5%−15,553.4%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$15M$0M
Change in diluted share count0.6%15.4%
Last close$85.35$50.44
P/E at the last close45.6×—
Insider trades, last 12 months——
Piotroski F-score—3 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
IRADIMEDPulse Biosciences
Operating margin
Percent of revenue
IRADIMEDPulse Biosciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
IRADIMEDPulse Biosciences

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the IRADIMED and Pulse Biosciences pages.